Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 198

    1.

    Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer.

    Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS.

    Ann Intern Med. 2003 Jan 21;138(2):90-7. Erratum in: Ann Intern Med. 2003 Nov 18;139(10):873. PMID: 12529090 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Chemotherapy in women with breast cancer.

    [No authors listed]

    Ann Intern Med. 2003 Jan 21;138(2):I16. No abstract available. PMID: 12529113 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996.

    Du X, Goodwin JS.

    Cancer. 2001 Aug 15;92(4):730-7.PMID: 11550141 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.

    J Natl Cancer Inst Monogr. 2006;(36):7-15.PMID: 17032888 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women.

    Du XL, Jones DV, Zhang D.

    J Gerontol A Biol Sci Med Sci. 2005 Sep;60(9):1137-44.PMID: 16183952 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?

    Woodard S, Nadella PC, Kotur L, Wilson J, Burak WE, Shapiro CL.

    Cancer. 2003 Sep 15;98(6):1141-9.PMID: 12973837 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Impact of a scientific presentation on community treatment patterns for primary breast cancer.

    Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Freeman J, Goodwin JS.

    J Natl Cancer Inst. 2006 Mar 15;98(6):382-8.PMID: 16537830 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997.

    Du XL, Key CR, Osborne C.

    Breast J. 2004 Sep-Oct;10(5):433-9.PMID: 15327498 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Adjuvant therapy for breast cancer: practice patterns of community physicians.

    Harlan LC, Abrams J, Warren JL, Clegg L, Stevens J, Ballard-Barbash R.

    J Clin Oncol. 2002 Apr 1;20(7):1809-17.PMID: 11919238 [PubMed - indexed for MEDLINE]Related articles

    12.

    Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

    Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

    J Clin Oncol. 2007 Jun 20;25(18):2522-7.PMID: 17577029 [PubMed - indexed for MEDLINE]Related articles

    13.

    Patterns of chemotherapy use for women with ovarian cancer: a population-based study.

    Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL.

    J Clin Oncol. 2003 Apr 15;21(8):1530-5.PMID: 12697877 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Clinical analysis of resectable breast cancer: a report of 6 263 cases]

    Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.

    Ai Zheng. 2005 Mar;24(3):327-31. Chinese. PMID: 15757535 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

    Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L; Cancer and Leukemia Group B.

    JAMA. 2005 Mar 2;293(9):1073-81.PMID: 15741529 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    19.

    Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer.

    Bhargava A, Du XL.

    Cancer. 2009 Jul 1;115(13):2999-3008.PMID: 19452539 [PubMed - indexed for MEDLINE]Related articles

    20.

    Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community.

    Studnicki J, Schapira DV, Bradham DD, Clark RA, Jarrett A.

    Cancer. 1993 Nov 15;72(10):2986-92.PMID: 8221566 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data